Average Co-Inventor Count = 7.16
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Forma Therapeutics, Inc. (33 from 125 patents)
2. Royal Appliance Mfg., Co. (12 from 234 patents)
3. Genentech, Inc. (10 from 3,221 patents)
4. Valo Health, Inc. (10 from 29 patents)
5. Forma Tm, LLC (9 from 10 patents)
6. Vita-mix Corporation (6 from 97 patents)
7. Valo Early Discovery, Inc. (6 from 15 patents)
8. Other (3 from 832,680 patents)
9. National City Bank (2 from 4 patents)
10. Techtronic Floor Care Technology Limited (1 from 240 patents)
82 patents:
1. 12336981 - Compounds and compositions for the inhibition of NAMPT
2. 11919839 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
3. 11891365 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
4. 11547701 - Compounds and compositions for the inhibition of NAMPT
5. 11485745 - Amido spirocyclic amide and sulfonamide derivatives
6. 11479564 - Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (NAMPT)
7. 11414392 - [6,6] fused bicyclic HDAC8 inhibitors
8. 11325917 - Thienopyrazine carboxamides as ubiquitin-specific protease inhibitors
9. 11279681 - 3-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
10. 11279687 - Compounds and compositions for the inhibition of NAMPT
11. 11111229 - Tetrahydroquinoline compositions as BET bromodomain inhibitors
12. 11084831 - Benzopiperazine compositions as BET bromodomain inhibitors
13. 10995078 - Compounds and compositions for inhibition of FASN
14. 10988450 - 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors
15. 10988441 - Alpha-cinnamide compounds and compositions as HDAC8 inhibitors